SLV-324 for advanced solid tumors that have spread
Part of Cancer clinical trials.
This phase 1 trial tests a new drug called SLV-324 for people with solid tumors that have spread and are no longer responding to standard treatments. The goal is to see if the drug is safe and works against the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your cancer has spread to other parts of the body and has gotten worse after standard treatments
- You can provide a recent tumor tissue sample (from a biopsy or past surgery)
- You have finished previous cancer treatments (surgery, chemo, radiation, etc.) at least 1 week before starting this study
- You have adequate organ function (kidney, liver, blood counts) as determined by blood tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special imaging agent called SLR-108 to take detailed PET scans of your cancer. It aims to see if this scan can help doctors better understand metastatic solid tumors that have grown after previous treatment.
This trial tests an experimental drug (called QLS5308) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug can shrink tumors or slow their growth, and to find the best dose with manageable side effects.
This trial tests a new combination of drugs for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the combination can shrink tumors and improve outcomes.
This trial tests new experimental cancer treatments and technologies for people with rare or hard-to-treat tumors. It aims to find tailored therapies that may work better for your specific cancer. You will be asked to provide a tumor sample for testing, and the trial team will guide you through the process.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This trial tests a new drug called LM-24C5 for people with advanced solid tumors that have stopped responding to standard treatments or who can't tolerate them. It aims to see if the drug is safe and effective.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.